Annexon (ANNX) Treasury Shares (2019 - 2026)
Annexon's (ANNX) quarterly Treasury Shares came in at $2.6 million in Q1 2026, up 68.15% year-on-year from $1.5 million in Q1 2025, and up 103.55% quarter-over-quarter from $1.3 million in Q4 2025.
Annexon (ANNX) Treasury Shares (2019 - 2026) Analysis & Trends
Annexon's Treasury Shares history runs 8 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- On a quarterly basis, Treasury Shares rose 68.15% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 68.15% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 62.7% from the prior year.
- Treasury Shares grew to $2.6 million in Q1 2026 per ANNX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.6 million in Q1 2026 and bottomed at $285655.0 in Q2 2022.
- The 5-year median for Treasury Shares is $770028.0 (2024), against an average of $912874.1.
- Across the five-year window, Treasury Shares jumped 1000.47% in 2022 and dropped 9.93% in 2023, its largest moves.
- Year by year, Treasury Shares stood at $550236.0 in 2022, then slipped by 9.93% to $495579.0 in 2023, then jumped by 55.38% to $770028.0 in 2024, then surged by 62.7% to $1.3 million in 2025, then soared by 103.55% to $2.6 million in 2026.
- Per Business Quant, the three latest ANNX Treasury Shares figures stand at $2.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55 Mn |
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 770,028.00 |
| Dec 31, 2024 | 770,028.00 |
| Sep 30, 2024 | 782,709.00 |
| Sep 30, 2024 | 782,709.00 |
| Jun 30, 2024 | 867,298.00 |
| Jun 30, 2024 | 867,298.00 |
| Mar 31, 2024 | 915,861.00 |
| Mar 31, 2024 | 915,861.00 |
| Dec 31, 2023 | 495,579.00 |
| Dec 31, 2023 | 495,579.00 |